α2-Adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra

Neuroscience

Volumn 115, Issue 4, 2002, Pages 1059-1065

  Cathala, L ^a,b   Guyon, A ^a   Eugene, D ^a   Paupardin Tritsch, D ^a  

^a CNRS   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

2 adrenoceptor; Cationic current; Dopaminergic neurone; Noradrenaline; Substantia nigra

Indexed keywords

2 (2 ETHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; IDAZOXAN; ISOPRENALINE; NEUROTENSIN; NORADRENALIN; PHENYLEPHRINE; PRESYNAPTIC RECEPTOR; YOHIMBINE; 4 AMINOBUTYRIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CATION TRANSPORT PROTEIN; DOPAMINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; INHIBITORY POSTSYNAPTIC POTENTIAL; INTRACELLULAR RECORDING; MALE; NERVE CONDUCTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; SYNAPSE; ACTION POTENTIAL; ADAPTATION; ANIMAL; METABOLISM; NERVE CELL; NERVE CELL INHIBITION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION; WISTAR RAT;

ACTION POTENTIALS; ADAPTATION, PHYSIOLOGICAL; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CATION TRANSPORT PROTEINS; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; MALE; NEURAL INHIBITION; NEURONS; NEUROTENSIN; NOREPINEPHRINE; PARKINSON DISEASE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

EID: 0037121443     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00542-0     Document Type: Article

References (35)

1. Adham N., Ellerbrock B., Hartig P., Weinshank R.L., Branchek T. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system. Mol. Pharmacol. 43:1993;427-433.
2. Aghajanian G.K., Bunney B.S. Pharmacological characterization of dopamine and 'autoreceptors' by microiontophoretic single-cell recording studies. Adv. Biochem. Psychopharmacol. 16:1977;433-438.
3. Berretta N., Bernardi G., Mercuri N.B. Alpha(1)-adrenoceptor-mediated excitation of substantia nigra pars reticulata neurons. Neuroscience. 98:2000;599-604.
4. Briley M. Noradrenergic mechanisms in Parkinson's disease. Trends Pharmacol. Sci. 14:1993;33-34.
5. H) in the rat substantia nigra pars compacta implicates the protein kinase C pathway. J. Physiol. 503:1997;87-97.
6. H and the inwardly rectifying potassium I(Kir) currents in the rat substantia nigra pars compacta. Eur. J. Neurosci. 11:1999;398-406.
7. Collingridge G.L., James T.A., MacLeod N.K. Neurochemical and electrophysiological evidence for a projection from the locus coeruleus to the substantia nigra [proceedings]. J. Physiol. 290:1979;44.
8. Colpaert, F., 1994. Noradrenergic mechanisms in Parkinson's disease: A theory. In: Briley, M. (Ed.), Noradrenergic Mechanisms in Parkinson's Disease. CRC, Boca Raton, FL, pp. 225-254.
9. Ernsberger P., Haxhiu M.A. The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla. Am. J. Physiol. 273:1997;R1572-R1579.
10. Farkas R.H., Chien P.Y., Nakajima S., Nakajima Y. Properties of a slow nonselective cation conductance modulated by neurotensin and other neurotransmitters in midbrain dopaminergic neurons. J. Neurophysiol. 76:1996;1968-1981.
11. Farkas R.H., Chien P.Y., Nakajima S., Nakajima Y. Neurotensin and dopamine D2 activation oppositely regulate the same K+ conductance in rat midbrain dopaminergic neurons. Neurosci. Lett. 231:1997;21-24.
12. Flavahan N.A., Vanhoutte P.M. Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins. J. Pharmacol. Exp. Ther. 238:1986;131-138.
13. Gaspar P., Stepniewska I., Kaas J.H. Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. J. Comp. Neurol. 325:1992;1-21.
14. Gonzalez-Hernandez T., Rodriguez M. Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat. J. Comp. Neurol. 421:2000;107-135.
15. Grenhoff J., Svensson T.H. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur. J. Pharmacol. 233:1993;79-84.
16. Grenhoff J., Nisell M., Ferre S., Aston-Jones G., Svensson T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural. Transm. Gen. Sect. 93:1993;11-25.
17. Grenhoff J., North R.A., Johnson S.W. Alpha 1-adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur. J. Neurosci. 7:1995;1707-1713.
18. Harrison J.K., Pearson W.R., Lynch K.R. Molecular characterization of alpha 1- and alpha 2-adrenoceptors. Trends Pharmacol. Sci. 12:1991;62-67.
19. Holmberg M., Scheinin M., Kurose H., Miettinen R. Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry. Neuroscience. 93:1999;1323-1333.
20. Jones L.S., Gauger L.L., Davis J.N. Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat. J. Comp. Neurol. 231:1985;190-208.
21. Jones C.R., Palacios J.M., Hoyer D., Buhler F.R. Receptor modification in the brains of spontaneously hypertensive and Wistar-Kyoto rats: regionally specific and selective increase in cerebellar beta 2-adrenoceptors. Br. J. Clin. Pharmacol. 30:1990;174S-177S.
22. Lacey M.G., Mercuri N.B., North R.A. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J. Physiol. 392:1987;397-416.
23. Lee A., Wissekerke A.E., Rosin D.L., Lynch K.R. Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience. 84:1998;1085-1096.
24. MacDonald E., Kobilka B.K., Scheinin M. Gene targeting-homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol. Sci. 18:1997;211-219.
25. Millan M.J., Newman-Tancredi A., Audinot V., Cussac D., Lejeune F., Nicolas J.P., Coge F., Galizzi J.P., Boutin J.A., Rivet J.M., Dekeyne A., Gobert A. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse. 35:2000;79-95.
26. Nicholas A.P., Pieribone V., Hokfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. Comp. Neurol. 328:1993;575-594.
27. Palacios J.M., Hoyer D., Cortes R. alpha 1-Adrenoceptors in the mammalian brain: similar pharmacology but different distribution in rodents and primates. Brain Res. 419:1987;65-75.
28. Pauwels P.J., Colpaert F.C. Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions. Br. J. Pharmacol. 131:2000;1385-1390.
29. Pieribone V.A., Nicholas A.P., Dagerlind A., Hokfelt T. Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J. Neurosci. 14:1994;4252-4268.
30. Pohjanoksa K., Jansson C.C., Luomala K., Marjamaki A., Savola J.M., Scheinin M. Alpha2-adrenoceptor regulation of adenylyl cyclase in CHO cells: dependence on receptor density, receptor subtype and current activity of adenylyl cyclase. Eur. J. Pharmacol. 335:1997;53-63.
31. Riad M., Garcia S., Watkins K.C., Jodoin N., Doucet E., Langlois X., el Mestikawy S., Hamon M., Descarries L. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol. 417:2000;181-194.
32. Rosin D.L., Talley E.M., Lee A., Stornetta R.L., Gaylinn B.D., Guyenet P.G., Lynch K.R. Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 372:1996;135-165.
33. Talley E.M., Rosin D.L., Lee A., Guyenet P.G., Lynch K.R. Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 372:1996;111-134.
34. White F.J., Wang R.Y. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J. Pharmacol. Exp. Ther. 231:1984;275-280.
35. Winzer-Serhan U.H., Raymon H.K., Broide R.S., Chen Y., Leslie F.M. Expression of alpha 2 adrenoceptors during rat brain development-II. Alpha 2C messenger RNA expression and [3H]rauwolscine binding. Neuroscience. 76:1997;261-272.